MEDmeetsTECH on Facebook
MEDmeetsTECH on Twitter

ABOUT CONFERENCE

Exciting 11th edition of MEDmeetsTECH is taking the event to the international sphere. 2020 and its unprecedented pandemic showed that we need to speed up with introducing and implementing digital health solutions worldwide and in every country. This event will provide an excellent opportunity for MedTech startups, inventors, clinicians, investors, business leaders, representatives of public and private institutions and open-minded students to learn from each other with a smart approach to technology in healthcare.

The 11th edition will for the first-time address topics on entering the U.S. market with digital health solutions. Experienced subject matter experts and representatives of investors from the U.S. will present ideas and opinions on how to break into the U.S. market.

Among expected the XI edition will be an international edition that will be promoted in Europe and for the first time will address topics of entering the U.S. market with digital health solutions.

Among expected speakers, we will host the representatives of public institutions in Europe responsible for implementing digital health solutions on a broad national scale, representatives of the clinical world, inventors, CEOs of startups, and investors.

International speakers will provide educational and informative presentations to support the growth of the international digital healthcare market and inspire new business opportunities.

These circumstances will be a fantastic opportunity for 9 chosen startups to pitch their solutions in front of an international audience.

 

Agenda MEDmeetsTECH #11

11:00  12:00

SESSION: TRENDS

Digital Health in the post-COVID-19 era. New perspectives are being shaped by the reality of the pandemic and new opportunities to innovate in healthcare are waiting to be discovered, developed, and implemented. This keynote lecture will feature international trends in digital health solutions and is dedicated to everyone searching for possibilities to improve healthcare outcomes and is interested in revolutionizing healthcare delivery processes to make healthcare more accessible and affordable.   

1) Henrique Martins, MD, PhD, MLaw, FIAHSI  Lisbon, Portugal

International trends in digital health solutions  new possibilities.

2) Piotr Jankowski, Professor, MD, PhD  Krakow, Poland

Digital solutions for prevention and management of chronic diseases.

 

12:15  13:15

DEBATE

How to speed up the implementation of digital health solutions and popularize its use. A passionate and inspirational discussion between representatives of governmental institutions, representatives of healthcare service providers, CEO’s of startups, business leaders and investors.

 Marcin Koprowski – Warsaw, Poland / Roche, Head of Technology Centre

– dr hab. n. med. Dorota Makarewicz  Agencja Badań Medycznych, p.o. Dyrektora Wydziału Nauki i Komercjalizacji

– TBD

 

13:15  14:45

SESSION: STARTUPS PRESENTATIONS

The 11th international edition of MEDmeetsTECH will be a fantastic opportunity for 9 chosen startups to pitch their solutions in front of an international audience. Fill out the form and submit your startup. Out of all submitted startups 9 of them will be selected to be presented at the conference.

APPLICATION FOR THE STARTUP SESSION

 

15:00  15:55

SESSION: KNOWLEDGE TRANSFER

1) TBD

New legislation for medical devices within EU is coming in May 2021. What you should know?

 

2) TBD

Reimbursement and digital health solutions. How to speed up the use of digital therapeutics?

 

16:00  21:00

SESSION: USA

 

16:00 – 16:30

1) Mark Stimpfig  Phoenix, USA; London, UK

Should you consider entering the US market?

 

16:35 – 18:10

2) US Welcomes MedTech and BioTech Inventors – get to know available resources.

 

16:35 – 17:05

2a) Arizona – business friendly state

Mark Stimpfig – Phoenix, USA

 

17:10 – 18:10

2b) Greater Boston – world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Discussion moderator: 
Tomasz Kierul – Boston, United States

Discussion participants: 
Christa Bleyleben – Boston, United States
Sarah Delude
Cambridge, Massachusetts, United States
Stas Gayshan 
Boston, United States
Celina Chang Cambridge, Massachusetts, United States

 

18:15 – 18:45

3) Clinical Pilot Programs – how to run an effective pilot program in the US market and the benefits to foreign companies.

Kaja Kuczynska – New Jersey, United States

Jeff Stinson – Arkansas, United States

Amy Hester  United States

 

18:50 – 19:20

4) What founders are looking for? Making the right connections.

Discussion moderator: 
Tomasz Kierul 
– Boston, United States

Discussion participant: 
Brian Smith – California, United States

 

19:25 – 19:55

5) TBD

How to approach FDA clearance?

 

20:00 – 20:15

6) Piotr Baczynski

Immersion – Case Study

 

20:20 – 20:35

7) Lukasz Koltowski  Warsaw, Poland

AioCare – Case Study

SPEAKERS

Henrique Martins, MD, PhD, MLaw, FIAHSI

He has a Medical Degree, Internal Medicine Speciality, a Master and PhD degrees in Management, and a Law Master’s degree (thesis on the Public Liability implications of AI in Health). He is a National Defence Auditor (National institute of Defence, Ministry of Defence, Portugal) He is a Medical Doctor and University Professor, teaching and researching in Digital Health, Healthcare Systems and Transformation, Leadership and Management education for Medical Students and Health Professionals. He was one of the first CMIOs in Portugal in 2009-2013 at Hospital Fernando Fonseca, Lisbon, where he implemented large EHR system and founded an Innovation Center in Big Data and Robotics. He is the past president of SPMS, Portugal's Digital Health Agency, where he led National eHealth efforts for close to 7 years. He represented Portugal for 8 years and was the former Member States co-chair of the EU eHealth Network, the highest policy body on eHealth in the Union. During the years at the Ministry of Health he was responsible for creating a health data sharing platform for all national health service compatible with the advanced GDPR principles as early as 2012, and negotiate this with the Portuguese National Data Protection Authority (CNDP) obtaining its fast approval in less then 5 months. He was directly responsible for legal and data protection issues while head of SPMS, creating and maturing management of data protection issues and fostering education in this area both inside SPMS and in the Portuguese NHS. In 2019 he established one of the first Digital Health ethics committee in an EU country. Elected Fellow of the International Academy of Health Sciences Informatics (within IMIA) in July 2020. Since August 2020 he has integrates the HL7 Europe Foundation Board of Diretors. He now works as an Academic in two high-ranked business schools (ISCTE-IUL, and Catholica Business School), one Public Policy Institute (ISCSP-UL) and one medical school (FCS-UIB), and on individual consulting projects in Healthcare Transformation and Digital Health (www.henriquemartins.eu). He has authored a series of papers some of which looking at new trends for digital health at Global, European, National and Hospital levels.

SESSION: TRENDS
Topic: International trends in digital health solutions – new possibilities.

Piotr Jankowski, Professor, MD, PhD

Piotr Jankowski is a cardiologist, specialised in invasive cardiology. Professor at the Jagiellonian University in Kraków (Poland). Secretary (2017-2019) and member of the Board (2011-2015) of the Polish Cardiac Society (PSC), Prof Jankowski was the chairman of the Health Promotion Committee of the PCS (2011-2017), chairman of the Working Group on Epidemiology and Prevention of the PCS (from 2009 to 2011). Appointed National CVD Prevention Coordinator for Poland (since 2010), Prof Jankowski is a member of the EAPC Prevention Implementation Committee (since 2018). Chairman of the Board of the Public Health Foundation (since 2018), member of the Board of the Krakow Association of Physicians (from 2011), Prof Jankowski is currently professor at the Jagiellonian University in Kraków and the Polish Mother's Memorial Hospital - Research Institute in Lodz (Poland). Author of over 400 scientific contributions and co-author of a number of scientific and clinical statements and guidelines, Prof Jankowski is the laureate of numerous scientific awards (among others: Award of the Minister of Health, Awards of the Polish Cardiac Society, Awards of the Polish Society of Hypertension, European Society of Hypertension Award, Award of the “Health Promotion” Foundation, “Honoris Gratia” Award). His main topics of scientific interest relate to the prevention of cardiovascular disease, hypercholesterolemia, hypertension, and mechanisms of atherosclerosis development and aging.

SESSION: TRENDS
Topic: Digital solutions for prevention and management of chronic diseases.

Mark Stimpfig

The London Development Director for Greater Phoenix Economic Council and co-founded Go to Market Global.

Mark is the London Development Director for Greater Phoenix Economic Council promoting accessing the US West Coast markets through The Connected Place. Mark co-founded Go to Market Global in 2017, having previously run national and international marketing programmes for clients like Sony, Dixons / PC World, Safeway, and Reuters. Mark is a Cambridge University History Graduate with over 25 years’ experience in marketing and consultancy working with technology brands in B2B and B2C both in the UK and internationally. Past clients include Reuters, Safeway, Dixons, Microsoft, Royal Mail, The UK Driving Standards Agency, International Student Identity Card and Sony. Currently Mark is working with trade bodies like the Department of International Trade, Tech Nation, Manchester Growth Company, The Mayor of London’s International Business Programme, Innovate UK, Innovate Finance and techUK as well as a range of US/ UK commercial partners including Avalara, WorldFirst and ABGi. Mark has developed an expertise in assisting and enabling digital businesses to ‘go to market’ internationally in key sectors like fin-tech, ed-tech, IoT, Cyber, eCommerce and healthcare.

SESSION: USA
Topic: Should you consider entering the US market?
Topic: Arizona – business friendly state

Kaja Kuczynska

Kaja is a successful founder of several ventures focusing on bridging the gap between US and European public and private companies. With a background in finance and manufacturing, she has built several successful consulting companies developing strategic models for B2B, B2C, and consumer-based product businesses. Kaja works closely with other start-up entrepreneurs in Eastern Europe and the Middle East, specifically female founder teams, to create an ecosystem of conscious driven companies. She is currently focusing on driving more venture capital funds towards female-founded companies as well as improving the way the financial industry looks at female investment.

SESSION: USA
Topic: Clinical Pilot Programs – how to run an effective pilot program in the US market and the benefits to foreign companies.

Tomasz Kierul

Co-Founder, SkyBrook Venture Partners, LLC

Leader in fundraising and organizational development, with 15+ years of experience in the field. Driven strategic thinker with a unique combination of business and organizational development acumen, with an emphasis on applying team-building techniques and strategies for stronger business growth. A supporter of diversity and inclusion.

SESSION: USA
Discussion moderator:
What founders are looking for? Making the right connections.

Discussion moderator: Greater Boston - world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Christa Bleyleben

Managing Partner, MassGlobal Partners, Boston, MA

Since 2009 Managing Partner of MassGlobal Partners and frequently partnering with the Cambridge Innovation Center (CIC), Christa supports startups with US market access and expansion, training, and mentoring of innovative international companies. Her particular focus is on the value proposition, pitch practice, financing & finding needed resources, and facilitating partnering at senior levels. Previously Christa was Executive Director of the Massachusetts Office of International Trade & Investment, President of the Massachusetts International Trade Council, and a Managing Director in Bank of America’s global investment group. Christa is an active angel investor and serves on several advisory boards. She holds an MBA from the Vienna University of Business.

SESSION: USA
Discussion participant:
Greater Boston - world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Celina Chang

Cambridge, Massachusetts, United States
Vice President, Science Operations & Strategic Relationships at LabCentral

Celina Chang is the vice president of business operations & technology at LabCentral. She leads corporate operations pertaining to science, technology and strategic relationships (EHS, IT and business development) and is an advisor for onsite lab operations. She explores strategic expansion opportunities for LabCentral and plays a key role in the design, buildout activities and launch for expansion projects such as the Pagliuca Harvard Life Lab, MIT’s The Engine, LabCentral’s 700 Main Street expansion, LabCentral 610 and LabCentral 238. She began her career in process development working on pediatric viral vaccines with Wyeth Pharmaceuticals then shifted her focus to tissue engineering for both topical and implantable biological medical devices. Prior to joining LabCentral, she spent close to two years as a senior scientist at InVivo Therapeutics, a company developing groundbreaking technologies for the treatment of spinal cord injuries (SCI) and more than six years at Pervasis Therapeutics, a company advancing new therapies to improve dramatically the outcomes of common vascular interventions. She joined the company while it was still an early-stage biotech and was instrumental in advancing several of its products through clinical trials. Pervasis was acquired by Shire. Celina earned her bachelor’s degree in bioengineering from Cornell University.

SESSION: USA
Discussion participant:
Greater Boston - world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Sarah Delude

Boston, Massachusetts, United States
International Business Strategy Manager at the City of Boston

Sarah has worked in international relations for over 10 years and joined the City of Boston in 2016. In this role Sarah focuses on scaling up international relations through public diplomacy, economic partnerships, business engagement, and marketing Boston as a global and welcoming city. Prior to joining the City of Boston, Sarah worked in public diplomacy as Head of the Politics, Press and Public Affairs Section at the British Consulate-General in Boston, where she also held the Policy and University Engagement portfolio. Sarah also held roles at the Center for European Studies, an interdisciplinary research center at Harvard University. There she was responsible for programming, communications, external relations, student advising, and Visiting Scholars Programs. Sarah earned a B.A. from Syracuse University in International Relations and a Master's degree from Harvard in Government.

SESSION: USA
Discussion participant:
Greater Boston - world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Stas Gayshan

Managing Director at CIC and Founder of CIC Boston. Stas leads the development of new CIC projects in the Americas, Asia, Australia, the Middle East, and beyond, connecting innovators across boundaries and borders. Stas works with governments, universities, large corporations, real estate developers, entrepreneurs, nonprofits, funders, and other stakeholders to solve difficult problems, build powerful, interwoven innovation ecosystems, and help cities craft lasting, impactful outcomes. A globally sought-after thought leader on innovation and entrepreneurship, Stas often speaks at conferences and judges startup competitions around the world.

SESSION: USA
Discussion participant:
Greater Boston - world’s top biotech hub. A conversation with local experts about Greater Boston’s unique ecosystem that invests in innovation and builds the next generation of global life-science businesses.

Brian Smith

Brian A. Smith is the Co-Founder and CEO of RedCrow™ Inc. direct investment and marketing platform presenting professionally vetted investment opportunities in innovative healthcare startups to an accredited crowd of investors. Backing a vision with social impact is at the heart of RedCrow™ investing.

Prior to RedCrow™ Brian was a Financial Advisor with Morgan Stanley Smith Barney, advising high net worth families. During that time he and his wife experienced the tragic loss of their first child 24 weeks into the pregnancy. It was at that pivotal moment when Brian decided to channel his investment career into meaningful work helping other families who experience complicated pregnancies. Brian left Morgan Stanley and adopted an active role in MindChild Medical, a pioneer in the development of non-invasive fetal heart monitoring. This experience and the writing of the 2012 JOBS Act had Brian began to envision a day when crowdfunding would evolve into an equity-based model vs donation-based. So in 2015, alongside Jerry Harrison, Brian founded RedCrow™ with a mission to democratize the investment process for people otherwise shut out of early-stage investing opportunities. In 2020, Brian also co-founded The MainStage. The MainStage provides companies with the tools to streamline fundraising. In creating a password-protected virtual deal room, The MainStage allows companies to showcase exciting content, including videos and stylistic pitch decks, to interested investors. He resides in Mill Valley, CA with his wife and two daughters.

SESSION: USA
Discussion participant: What founders are looking for? Making the right connections.

Piotr Baczyński

Piotr Baczyński, born in 1986, founder and CEO of Immersion, one of the first companies in the world to specialize in solutions for business using virtual and augmented reality (VR / AR) technology. Immersion has completed many projects for Polish and foreign clients, cooperating with, among others, Bayer, Merck, the U.S. Department of Veteran Affairs NASA, the Smithsonian Institute, and the Museum of Natural History in New York. Immersion projects have been awarded and nominated for international awards such as Emmy, Webby and SXSW. Previously, he was the president and co-founder of Esencja Studio, an interactive agency that creates interactive and advertising solutions, including in a project develoed in cooperation with Facebook. Author of numerous marketing campaigns for clients such as Microsoft, Polkomtel, Orange, T-Mobile. Placed several times in the "50 most creative in business" ranking, nominated for the 2020 Ambassador of Polish Innovation award. He studied political science at the University of Warsaw. He lectured on the application of social media in politics at the European Academy of Diplomacy.

Topic: Case study 1 - Immersion

Lukasz Koltowski, MD, PhD

Lukasz Koltowski is an employee of the 1st Department and Clinic of Cardiology, Medical University of Warsaw, a member of the Board of the IT and Telemedicine Committee of the Polish Cardiac Society, and an expert in the field of mobile health and telemedicine. He gained experience, among others at John Radcliffe Hospital, Oxford (UK) and Karolinska Institute in Stockholm (Sweden). Since 2009, he has been actively describing and commenting on the most important events and solutions in the field of mHealth, editing the Efektywny Doctor blog (www.koltowski.com). He is a member of several scientific consortia, the creator and originator of the AioCare mobile spirometer, and the author of numerous mobile applications supporting the work of doctors. Lukasz Koltowski is an employee of the 1st Department and Clinic of Cardiology, Medical University of Warsaw, a member of the Board of the IT and Telemedicine Committee of the Polish Cardiac Society, and an expert in the field of mobile health and telemedicine. He gained experience, among others at John Radcliffe Hospital, Oxford (UK) and Karolinska Institute in Stockholm (Sweden). Since 2009, he has been actively describing and commenting on the most important events and solutions in the field of mHealth, editing the Efektywny Doctor blog (www.koltowski.com). He is a member of several scientific consortia, the creator and originator of the AioCare mobile spirometer, and the author of numerous mobile applications supporting the work of doctors.

Topic: Case study 1 - AioCare

Amy Hester, MD

Co-Founder, Chairwoman and CEO of HD Nursing. Her 25 years of nursing experience include over a decade of med/surge and neuro nursing followed by unit management and hospital administration. In 2015, she earned a Doctorate of Philosophy in Nursing Science and has since published and spoken extensively on the subject of falls and injury prediction and prevention and is an international thought leader in patient safety. Dr. Hester sits on the Board of the National Association of African Americans with Cystic Fibrosis. She retired from UAMS in 2018 after 26 years of service to dedicate her time fully to HD Nursing while remaining adjunct faculty in the UAMS CON. As an entrepreneur she mentors nurse innovators to help them with their own endeavors and serves as a clinician in residence for HealthTech Arkansas.

SESSION: USA
Topic: Clinical Pilot Programs – how to run an effective pilot program in the US market and the benefits to foreign companies.

Jeff Stinson, CPA, MBA

Mr. Stinson founded and leads HealthTech Arkansas, a healthcare accelerator and early stage investment fund that immerses world class, early stage healthcare companies from around the country into Arkansas’ leading hospital systems and physician practices.

Additionally, Mr. Stinson founded and serves as executive director of the Fund for Arkansas’ Future, an “angel” investor fund that invests in early stage, Arkansas-based companies. Now investing from its second fund, the two funds combined have 100 individual investors - representing some of Arkansas’ most distinguished business and community leaders – and investments in over 30 technology based businesses. The fund seeks companies with innovative business models and the ability to grow rapidly, and has formally reviewed over 700 applications for investment since inception.

Mr. Stinson began his career in 1990 as a CPA with the Nashville, Tennessee office of a Big 5 public accounting firm, representing clients in the health care, banking, manufacturing, and printing and publishing industries. Subsequently, in his role as Director of Marketing for a large, publicly traded health care organization, he was instrumental in developing strategic plans for individual business units to position those units for long-term success.

After obtaining his MBA, with honors, from the Owen School of Management at Vanderbilt University, he moved to Little Rock in 1999 and has worked extensively in the private equity markets. In 2001, he launched and developed his own successful business advisory practice which has included leading the technology transfer office at University of Arkansas Little Rock.

His past board service includes President of the Board of Directors for Youth Home, Inc., Commissioner on the Little Rock Sister Cities Commission, Little Rock Sister Cities Foundation Board, Arkansas Motion Picture Institute, Advisory Board for TechPreneur, Arkansas Venture Forum Committee, and volunteer for Easter Seals Arkansas, American Cancer Society, Our House, CARE for Animals, Vision Little Rock, and the Governor’s Cup student business plan competition. He has been a mentor for the ARK Challenge business accelerator and Venture Center FinTech accelerator, and volunteer speaker for Arkansas Scholars and Volunteers in Public Schools. He is a graduate of Leadership Greater Little Rock, Class XVI, and was a 2006 Arkansas Business “40 Under 40” honoree.

SESSION: USA
Topic: Clinical Pilot Programs – how to run an effective pilot program in the US market and the benefits to foreign companies.

DEBATE

Marcin Koprowski

Marcin leads the Technology Center at Roche Global IT Solution Center, Roche's global software powerhouse. He works with a portfolio focused on Research and Early Development as well as novel Diagnostics solutions, including digital products. Being an enthusiast of digital healthcare transformation and open-innovation ecosystems, he also co-leads the development of Roche's partnerships with startups and other innovative companies & institutions. Marcin is an entrepreneur by heart, with hands-on startup experience he gained prior to joining Roche.

Fill out the form and submit your startup!

- list of startups submitted to the previous editions of the conference -

- guidelines for startups how to present during the conference -

APPLICATION FOR THE STARTUP SESSION

PARTNERS & SPONSORS

Strategic media partner

Startup Poland

Media

About Digital Health
Akademia Managera
Biotechnologia
Dla Szpitali
Dla Zdrowia
Medical Press
MEDtube
OPM
Puls Medycyny
Poradnik Zdrowie
Rynek Zdrowia
SMiF
Terapia

Partners

GPNT
Med Silesia
SpeedUp Group

Organizer

CTM
The website uses cookies and other technologies of automatic data storage for analytical purposes, service provision and security, excluding profiling. By using the Website without changing the browser settings, cookies will be automatically saved in the device's memory. Analytical data on how the Customer uses the Website are processed by external entities cooperating with the Service Provider. More information in the Regulations of the Website.
I understand and agree